MYNDF Stock Price, Chart, Stats & News

MYND Life Sciences Inc.
Save
MYND Life Sciences Inc. (MYNDF) does not currently pay a dividend.
657,843
Market cap
–
Current P/E
–
Forward P/E
MYNDF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
MYND Life Sciences Inc. operates as a neuro-pharmaceutical company, applying life science principles to develop innovative treatments for depressive conditions. The firm conducts scientific research and clinical trials in Canada and the United States, concentrating on therapeutic compounds that possess neuro-anti-inflammatory properties. A significant part of its research involves the in-depth study of psilocin and psilocybin extracts, along with their various analogs.
Similar securities
Based on sector and market capitalization
Report issue





